These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9835830)

  • 1. Safety and efficacy of a novel tartar control dentifrice containing 3.3% pyrophosphate: a controlled six-month clinical trial.
    Segreto VA; Stevens DP; Schulte MC; Fortna RH; Gerlach RW
    J Clin Dent; 1998; 9(1):26-9. PubMed ID: 9835830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticalculus efficacy and safety of a novel whitening dentifrice containing sodium hexametaphosphate: a controlled six-month clinical trial.
    Liu H; Segreto V; Baker R; Vastola K; Ramsey L; Gerlach R
    J Clin Dent; 2002; 13(1):25-8. PubMed ID: 11507928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quanticalc assessment of the clinical scaling benefits provided by pyrophosphate dentifrices with and without triclosan.
    White DJ; Bollmer BW; Baker RA; Cox ER; Perlich MA; McClanahan SF; Beiswanger BB; Mau M; Tuohy M; Arends J
    J Clin Dent; 1996; 7(2 Spec No):46-9. PubMed ID: 9238897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of extrinsic stain using a tartar control whitening dentifrice: a randomized clinical trial.
    Gerlach RW; White DJ
    J Clin Dent; 2001; 12(2):42-6. PubMed ID: 11476013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of two tartar control dentifrices: a twelve-week study.
    Sowinski J; Petrone DM; Battista G; Petrone ME; DeVizio W; Volpe AR
    J Clin Dent; 1998; 9(4):101-4. PubMed ID: 10518859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crest Tartar Control benefits assessed by Quanticalc: clinical method and three-month results.
    Dijkman AG; Arends J; Ruben JR; White DJ; Cox ER; Bollmer BW
    J Clin Dent; 1996; 7(2 Spec No):41-5. PubMed ID: 9238896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of tooth color after prophylaxis: comparison of three dentifrices.
    Isaacs RL; Bartizek RD; Owens TS; Walters PA; Gerlach RW
    J Clin Dent; 2001; 12(2):51-5. PubMed ID: 11476015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticalculus effects of a novel, dual-phase polypyrophosphate dentifrice: chemical basis, mechanism, and clinical response.
    White DJ; Gerlach RW
    J Contemp Dent Pract; 2000 Nov; 1(4):1-19. PubMed ID: 12167947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical anticalculus efficacy of a tartar control whitening dentifrice for the prevention of supragingival calculus in a three-month study.
    Sowinski J; Petrone DM; Battista G; Petrone ME; Crawford R; Patel S; DeVizio W; Chaknis P; Volpe AR; Proskin HM
    J Clin Dent; 1999; 10(3 Spec No):107-10. PubMed ID: 10825856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A twelve-week clinical comparison of two tartar control dentifrices.
    Sowinski J; Battista G; Petrone DM; Petrone ME; DeVizio W; Volpe AR; Proskin HM
    J Clin Dent; 2000; 11(3):76-9. PubMed ID: 11460609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A calculus clinical study comparing the efficacy of two commercially available dentifrices.
    Sowinski J; Battista G; Petrone DM; Petrone ME; DeVizio W; Volpe AR; Proskin HM
    J Clin Dent; 2000; 11(3):68-71. PubMed ID: 11460607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative efficacy of two commercial tartar control dentifrices in preventing calculus development and facilitating easier dental cleanings.
    White DJ; McClanahan SF; Lanzalaco AC; Cox ER; Bacca L; Perlich MA; Campbell SL; Schiff T; Stains A
    J Clin Dent; 1996; 7(2 Spec No):58-64. PubMed ID: 9238900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical comparison of two calculus-inhibiting dentifrices.
    Conforti N; Berta R; Petrone ME; DeVizio W; Volpe AR; Proskin HM
    J Clin Dent; 2000; 11(3):72-5. PubMed ID: 11460608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a tartar control whitening dentifrice on tooth shade in a population with long-standing natural stain.
    Gerlach RW; Barker ML; Hyde JD; Jones MB; Cordero RE
    J Clin Dent; 2001; 12(2):47-50. PubMed ID: 11476014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triclosan/pyrophosphate dentifrice: dental plaque and gingivitis effects in a 6-month randomized controlled clinical study.
    Grossman E; Hou L; Bollmer BW; Court LK; McClary JM; Bennett S; Winston JL; McClanahan SF
    J Clin Dent; 2002; 13(4):149-57. PubMed ID: 12116725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative intraoral tolerance of sodium hexametaphosphate and pyrophosphate antitartar dentifrices.
    Gerlach R
    J Clin Dent; 2002; 13(1):29-32. PubMed ID: 11507929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study to compare the anticalculus efficacy of three dentifrice formulations.
    Allen DR; Battista GW; Petrone DM; Petrone ME; DeVizio W; Volpe AR
    J Clin Dent; 2002; 13(2):69-72. PubMed ID: 11695209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new appliance to evaluate the clinical efficacy of dental calculus control agents.
    Xu T; Richter R; Mattai J
    J Clin Dent; 2003; 14(4):98-102. PubMed ID: 14666741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of lingual calculus formation with daily use of 6% H2O2/2% pyrophosphate whitening strips.
    Farrell S; Barker ML; Gerlach RW; Putt MS; Milleman JL
    J Clin Dent; 2009; 20(3):75-8. PubMed ID: 19711607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study to evaluate the anticalculus effect of a dentifrice on calculus formation].
    Taner IL; Kebudi E; Taplamacioğlu B
    Ankara Univ Hekim Fak Derg; 1990 Jan; 17(1):45-9. PubMed ID: 1966541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.